Procyon Corporation

PCYN · OTC Markets OTCPK · Stock · Healthcare
$0.27
+0.00% today
Delayed price,

What Procyon does

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. The company also offers AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and helix collagen gel. It sells its products to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through distributors, and direct and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.

Key facts

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$2.2M
P/E (ttm)
—
Forward P/E
—
Dividend yield
0.00%
Beta
61694.68
Profit margin
-6.8%
Employees
19
Headquarters
Oldsmar, FL, United States
Exchange
OTC Markets OTCPK

Performance

1 Month
+3.8%
3 Months
+8.0%
6 Months
-3.6%
1 Year
+119.5%
5 Years
-13.2%
$0.1252-week range$0.28
Biggest setback — last 12 months
-28.2%
23 Mar 2026 → 20 Apr 2026
Fell from $0.28 to $0.20 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+131.4%
20 Oct 2025 → 23 Mar 2026
Ran from $0.12 to $0.28 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$0.22 (-20.1%)$0.27$0.34 (+25.1%)
3 Months$0.18 (-32.1%)$0.27$0.40 (+47.4%)
6 Months$0.16 (-42.2%)$0.27$0.47 (+73.1%)
12 Months$0.12 (-54.0%)$0.27$0.59 (+117.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 77.6%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent insider activity

Sold 80,000 shares at $0.18 — SPEER FOUNDATION, 10% Owner · 2024-06-27
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.